Induction of Foxp3-Expressing Regulatory T-Cells by Donor Blood Transfusion Is Required for Tolerance to Rat Liver Allografts

Background Donor-specific blood transfusion (DST) prior to solid organ transplantation has been shown to induce long-term allograft survival in the absence of immunosuppressive therapy. Although the mechanisms underlying DST-induced allograft tolerance are not well defined, there is evidence to suggest DST induces one or more populations of antigen-specific regulatory cells that suppress allograft rejection. However, neither the identity nor the regulatory properties of these tolerogenic lymphocytes have been reported. Therefore, the objective of this study was to define the kinetics, phenotype and suppressive function of the regulatory cells induced by DST alone or in combination with liver allograft transplantation (LTx). Methodology/Principal Findings Tolerance to Dark Agouti (DA; RT1a) rat liver allografts was induced by injection (iv) of 1 ml of heparinized DA blood to naïve Lewis (LEW; RT1l) rats once per week for 4 weeks prior to LTx. We found that preoperative DST alone generates CD4+ T-cells that when transferred into naïve LEW recipients are capable of suppressing DA liver allograft rejection and promoting long-term survival of the graft and recipient. However, these DST-generated T-cells did not express the regulatory T-cell (Treg) transcription factor Foxp3 nor did they suppress alloantigen (DA)-induced activation of LEW T-cells in vitro suggesting that these lymphocytes are not fully functional regulatory Tregs. We did observe that DST+LTx (but not DST alone) induced the time-dependent formation of CD4+Foxp3+ Tregs that potently suppressed alloantigen-induced activation of naïve LEW T-cells in vitro and liver allograft rejection in vivo. Finally, we present data demonstrating that virtually all of the Foxp3-expressing Tregs reside within the CD4+CD45RC− population whereas in which approximately 50% of these Tregs express CD25. Conclusions/Significance We conclude that preoperative DST, in the absence of liver allograft transplantation, induces the formation of CD4+ T-cells that are not themselves Tregs but give rise directly or indirectly to fully functional CD4+CD45RC−Foxp3+Tregs when transferred into MHC mismatched recipients prior to LTx. These Tregs possess potent suppressive activity and are capable of suppressing acute liver allograft rejection. Understanding the mechanisms by which preoperative DST induces the generation of tolerogenic Tregs in the presence of alloantigens may lead to the development of novel antigen-specific immunological therapies for the treatment of solid organ rejection.

[1]  S. Brouard,et al.  Development of CD25– regulatory T cells following heart transplantation: Evidence for transfer of long‐term survival , 2007, European journal of immunology.

[2]  D. Ostanin,et al.  Combination of donor-specific blood transfusion with anti-CD28 antibody synergizes to prolong graft survival in rat liver transplantation. , 2006, Transplantation proceedings.

[3]  C. Mathieu,et al.  Early Presence of Regulatory Cells in Transplanted Rats Rendered Tolerant by Donor-Specific Blood Transfusion1 , 2005, The Journal of Immunology.

[4]  K. Ley,et al.  Expanded B cell population blocks regulatory T cells and exacerbates ileitis in a murine model of Crohn disease. , 2004, The Journal of clinical investigation.

[5]  M. W. Flye,et al.  Development of Infectious Tolerance After Donor-Specific Transfusion and Rat Heart Transplantation 1 , 2003, The Journal of Immunology.

[6]  G. Mazariegos,et al.  Posttransplant Lymphoproliferative Disorders in Liver Transplantation: A 20-Year Experience , 2002, Annals of surgery.

[7]  M. W. Flye,et al.  Donor-specific antigen transfusion-mediated cardiac allograft tolerance is prevented by prior treatment with anti-CD8, but not anti-CD4, antibody. , 2001, Transplantation proceedings.

[8]  J. Soulillou,et al.  Reassessment of the role of CD8+ T cells in the induction of allograft tolerance by donor‐specific blood transfusion , 1999, European journal of immunology.

[9]  S. Ménoret,et al.  A critical role for transforming growth factor-beta in donor transfusion-induced allograft tolerance. , 1998, The Journal of clinical investigation.

[10]  Y. Vanrenterghem,et al.  Prospective evaluation of pretransplant blood transfusions in cadaver kidney recipients. , 1997, Transplantation.

[11]  A. Tominaga,et al.  Persistent infiltration of CD45RC−CD4+ T cells, Th2‐like effector cells, in prolonging hepatic allografts in rats pretreated with a donor‐specific blood transfusion , 1997, Hepatology.

[12]  Y. Yamaguchi,et al.  Prolonged survival of rat hepatic allografts pretreated with a single donor-specific blood transfusion: the distribution of donor cells expressing class I major histocompatibility complex antigens in the recipient. , 1996, The Journal of surgical research.

[13]  T. Mohanakumar,et al.  Donor-specific transfusions have long-term beneficial effects for human renal allografts. , 1995, Transplantation.

[14]  M. Hallet,et al.  PERIPHERAL TOLERANCE OF AN ALLOGRAFT IN ADULT RATS—CHARACTERIZATION BY LOW INTERLEUKIN‐2 AND INTERFERON‐γ mRNA LEVELS AND BY STRONG ACCUMULATION OF MAJOR HISTOCOMPATIBILITY COMPLEX TRANSCRIPTS IN THE GRAFT , 1992, Transplantation.

[15]  J. Alexander,et al.  The induction of immunologic hyporesponsiveness by preoperative donor-specific transfusions and cyclosporine in human cadaveric transplants. A preliminary trial. , 1992, Transplantation.

[16]  G. Babcock,et al.  THE INDUCTION OF IMMUNOLOGIC HYPRESPONSIVENESS BY PREOPERATIVE DONOR‐SPECIFIC TRANSFUSIONS AND CYCLOSPORINE IN HUMAN CADAVERIC TRANSPLANTS , 1992 .

[17]  W. Kast,et al.  Pretransplantation blood transfusion revisited. , 1991, The New England journal of medicine.

[18]  R. Busuttil,et al.  Donor-specific serum transfusion prolongs survival of orthotopic liver transplantation in the rat. , 1989, Transplantation proceedings.

[19]  K. Wood,et al.  Transfusion induces blood donor-specific suppressor cells. , 1989, Journal of immunology.

[20]  M. Goldman,et al.  PRETRANSPLANT TRANSFUSIONS IN CARDIAC ALLOGRAFT RECIPIENTS , 1987, Transplantation.

[21]  J. Bradley,et al.  Prolonged survival of actively enhanced rat renal allografts despite accelerated cellular infiltration and rapid induction of both class I and class II MHC antigens , 1987, The Journal of experimental medicine.

[22]  M. Dallman,et al.  Specific cytotoxic T cells are found in the nonrejected kidneys of blood-transfused rats , 1987, The Journal of experimental medicine.

[23]  R. Calne,et al.  ORTHOTOPIC LIVER TRANSPLANTATION IN THE RAT: TECHNIQUE USING CUFF FOR PORTAL VEIN ANASTOMOSIS AND BILIARY DRAINAGE , 1979, Transplantation.

[24]  Asphalt Pavement Mixes,et al.  DEVELOPMENT OF A , 2011 .

[25]  O. Salvatierra,et al.  Are blood transfusions beneficial in the cyclosporine era? , 2004, Pediatric Nephrology.

[26]  Nina Singh,et al.  Infections in solid organ transplant recipients. , 2000, Current opinion in infectious diseases.

[27]  R. Bollinger,et al.  The role of class I major histocompatibility complex antigens in prolonging the survival of hepatic allografts in the rat. , 1989, Transplantation.